Biomarkers in transplantation medicine: Prediction of pharmacodynamic drug effects

Transfusion Medicine and Hemotherapy

Volumn 34, Issue 3, 2007, Pages 182-187

  Barten, Markus J ^a   Gummert, Jan F ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Biomarkers; Dendritic cells; Flow cytometry; Immunosuppressive drugs; Pharmacodynamics; T cells; Transplantation; Whole blood

Indexed keywords

CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

BLOOD ANALYSIS; BLOOD SAMPLING; CARDIAC GRAFT REJECTION; DENDRITIC CELL; DISEASE MARKER; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MONITORING; FLOW CYTOMETRY; GENETIC HETEROGENEITY; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PREDICTION; REVIEW; T LYMPHOCYTE SUBPOPULATION;

EID: 34249997798     PISSN: 16603796     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101372     Document Type: Review

References (60)

1. Kahan BD: Therapeutic drug monitoring of immunosuppressant drugs in clinical practice. Clin Ther 2002;24:330-350.
2. Oellerich M, Barten MJ, Armstrong VW: Biomarkers: the link between therapeutic drug monitoring and pharmacodynamics. Ther Drug Monit 2006;28:35-38.
3. Valet G: Human cytome project, cytomics, and systems biology: the incentive for new horizons in cytometry. Cytometry A 2005;64A:1-2.
4. Tárnok A, Valet GK, Emmrich F: Systems biology and clinical cytomics: The 10th Leipziger Workshop and the 3rd International Workshop on Slide-Based Cytometry, Leipzig, Germany, April 2005. Cytometry A 2006; 69A:36-40.
5. Lenz D, Barten MJ, Hiller S, Tárnok A: Regenerative and predictive medicine of cardiovascular disease: the 9th Leipziger workshop and the 2nd international workshop on slide based cytometry. Cytometry A 2005;64A:110-114.
6. Sbrana S, Bevilacqua S, Buffa M, Spiller D, Parri MS, Gianetti J, De Filippis R, Clerico A: Post-reperfusion changes of monocyte function in coronary blood after extracorporeal circulation. Cytometry B Clin Cytom 2005;65B:14-21.
7. Bocsi J, Richter M, Hambsch J, Barten MJ, Dahnert I, Schneider P, Tárnok A: Transient Th1/Th2 disbalance indicates postoperative effusions and edema after cardiopulmonary bypass in children. Cytometry A 2006;69A:165-168.
8. Barten MJ, van Gelder T, Gummert JF, Boecke K, Shorthouse R, Billingham M, Morris RE: Pharmacodynamics of mycophenolate mofetil after heart transplantation: new mechanisms of action and correlations with histologic severity of graft rejection. Am J Transplant 2002;2:719-732.
9. Barten MJ, Streit F, Boeger M, Dhein S, Tárnok A, Shipkova M, Armstrong VW, Mohr FW, Oellerich M, Gummert JF: Synergistic effects of sirolimus and tacrolimus: Analysis of immunosuppression on lymphocyte proliferation and activation in whole blood. Transplantation 2004;77:1154-1162.
10. Barten MJ, Shipkova M, Bartsch P, Dhein S, Streit F, Tárnok A, Armstrong VW, Mohr FW, Oellerich M, Gummert JF: Mycophenolic acid interaction with cyclosporine and tacrolimus in vitro and in vivo. Evaluation of additive effects on rat blood lymphocyte function. Ther Drug Monit 2005;27:123-131.
11. Barten MJ, Gummert JF, van Gelder T, Shorthouse R, Morris RE: Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood: inhibition by immunosuppressive drugs in vitro. J Immunol Methods 2001;253:95-112.
12. Böhler T, Nolting J, Kamar N, Gurragchaa P, Reisener K, Glander P, Neumayer HH, Budde K Klupp J: Validation of immunological biomarkers for the pharmacodynamic monitoring of immunosuppressive drugs in humans. Ther Drug Monit 2007;29:77-86.
13. Barten MJ, Dhein S, Chang H, Bittner HB, Tárnok A, Rahmel A, Mohr FW, Gummert JF: Assessment of immunosuppressive drug interaction: inhibition of lymphocyte function in peripheral human blood. J Immunol Methods 2003;283:99-114.
14. Ramanathan M: Flow cytometry applications in pharmacodynamics and drug delivery. Pharm Res 1997;14:1106-1114.
15. Schlenke P: Leukocyte reduction in blood component supply: the impact of flow cytometry in assessing residual leukocytes. Transfus Med Hemother 2005;32:12-19.
16. Gille C, Orlikowsky T: Flow cytometric methods in the detection of neonatal infection. Transfus Med Hemother 2007;34(3):157-163.
17. Kamprad M, Kindler S, Schuetze N, Emmrich F: Flow cytometric immunophenotyping of umbilical cord and peripheral blood hematopoietic progenitor cells by different CD34 epitopes, CD133, P-glycoprotein expression and rhodamine-123 efflux. Transfus Med Hemother 2007;34(3):195-203.
18. Gummert JF, Barten MJ, Sherwood SW, van Gelder T, Morris RE: Pharmacodynamics of immunosuppression by mycophenolic acid: inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics. J Pharmacol Exp Ther 1999;291:1100-1112.
19. Suni MA: Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry. J Immunol Methods 1998;212:89-98.
20. Barten MJ, Rahmel A, Bocsi J, Boldt A, Garbade J, Dhein S, Mohr FW, Gummert JF: Cytokine analysis to predict immunosuppression. Cytometry A 2006;69A:155-157.
21. Boldt A, Barten MJ, Weiss C, Sagner A, Mohr FW, Gummert JF: Novel apoptosis assay to analyze immunosuppression. Cytometry A 2006;69:158-160.
22. Athanassopoulos P, Vaessen LMB, Maat APWM, Balk AHMM, Weimar W, Bogers AJJC: Peripheral blood dendritic cells in human end-stage heart failure and the early post-transplant period: evidence for systemic Th1 immune responses. Eur J Card Thor Surg 2004;25:619-626.
23. Bueno C, Almeida J, Alguero MC, Sanchez ML, Vaquero JM, et al: Flow cytometric analysis of cytokine production by normal human peripheral blood dendritic cells and monocytes: comparative analysis of different stimuli, secretion-blocking agents and incubation periods. Cytometry 2001;46:33-40.
24. Halloran PF: Immunosuppressive drugs for kidney transplantation. N Engl J Med 2004;351:2715-2729.
25. Takahashi K, Reynolds M, Ogawa N, Longo DL, Burdick J: Augmentation of T-cell apoptosis by immunosuppressive agents. Clin Transplant 2004;18:72-75.
26. Khanna AK: Mechanism of the combination immunosuppressive effects of rapamycin with either cyclosporine or tacrolimus. Transplantation 2000;70:690-694.
27. Ferron GM, Pyszczynski NA, Jusko WJ: Gender-related assessment of cyclosporine/prednisolone/sirolimus interactions in three human lymphocyte proliferation assays. Transplantation 1998;65:1203-1209.
28. Dumont FJ, Melino MR, Staruch MJ, Koprak SL, Fischer PA, Sigal NH: The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells. J Immunol 1990;144:1418-1424.
29. Kung L, Halloran PF: Immunophilins may limit calcineurin inhibition by cyclosporine and tacrolimus at high drug concentrations. Transplantation 2000;70:327-335.
30. Grinyó JM, Cruzado JM, Millán O, Caldes A, Sabate I, Gil-Vernet S, Seron D, Brunet M, Campistol JM, Torras J, Martorell J: Low-dose cyclosporine with mycophenolate mofetil induces similar calcineurin activity and cytokine inhibition as does standard-dose cyclosporine in stable renal allografts. Transplantation 2004;78:1400-1403.
31. Hartmann B, Schmid G, Graeb C: Biochemical monitoring of mTOR inhibitor-based immunosuppression following kidney transplantation: a novel approach for tailored immunosuppressive therapy. Kidney Int 2005;68:2593-2598.
32. Budde K, Glander P, Bauer S, Braun K, Waiser J, Fritsche L, Mai I, Roots I, Neumayer HH: Pharmacodynamic monitoring of mycophenolate mofetil. Clin Chem Lab Med 2000;38:1213-1216.
33. Cadillo-Chavez R, deEchgaray S, Santiago-Delpin EA: Assessing the risk of infection and rejection in Hispanic renal transplant recipients by means of an adenosine triphosphate release assay. Transplant Proc 2006;38:918-920.
34. Stein CM, Murray JJ, Wood AJJ: Inhibition of stimulated interleukin-2 production in whole blood: a practical measure of cyclosporine effect. Clin Chem 1999;45:1477-1484.
35. Stalder M, Brisan T, Holm B, Haririfar M, Scandling J, Morris RE: Quantification of immunosuppression by flow cytometry in stable renal transplant recipients. Ther Drug Monit 2003;25:22-27.
36. Haertel C, Fricke L, Schuhmacher N, Kirchner H, Müller-Steinhardt M: Delayed cytokine mRNA expression kinetics after T-lymphocyte costimulation: a quantitative measure of the efficacy of cyclosporin A-based immunosuppression. Clin Chem 2002;48:2225-2231.
37. van den Berg AP, Twilhaar WN, Mesander G: Quantitation of immunosuppression by flow cytometric measurement of the capacity of T cells for interleukin-2 production. Transplantation 1998;65:1066-1071.
38. Giese T, Zeier M, Schemmer P, Uhl W, Schoels M, Dengler T, Buechler M, Meuer S: Monitoring of NFAT-regulated gene expression in the peripheral blood of allograft recipients: a novel perspective toward individually optimized drug doses of cyclosporine A. Transplantation 2004;77:339-344.
39. Hodge G, Hodge S, Reynolds P, Holmes M: Intracellular cytokines in blood T cells in lung transplant patients - a more relevant indicator of immunosuppression than drug levels. Clin Exp Immunol 2005;139:159-164.
40. Sommerer C, Konstandin M, Dengler T, Schmidt J, Meuer S, Zeier M, Giese T: Pharmacodynamic monitoring of cyclosporine a in renal allograft recipients shows a quantitative relationship between immunosuppression and the occurrence of recurrent infections and malignancies. Transplantation 2006;82:1280-1285.
41. Barten MJ, Tárnok A, Garbade J, Bittner HB, Dhein S, Mohr FW, Gummert JF: Pharmacodynamics of T-cell functions for monitoring immunosuppression. Cell Prolif 2007;40:50-63.
42. Brunet M, Campistol JM, Millan O, Vidal E, Esforzado N, Rojo I, Jimenez O, Oppenheimer F, Corbella J, Martorell J: Pharmacokinetic and pharmacodynamic correlations of cyclosporine therapy in stable renal transplant patients: evaluation of long-term target C2. Int Immunopharmacol 2003;3:987-999.
43. Boldt A, Barten MJ, Sagner A, Mohr FW, Adams V, Dhein S, Gummert JF: The influence of immunosuppressive drugs on T-and B-cell apoptosis via P53-mediated pathway in vitro and in vivo. Transplantation 2006;15:422-1427.
44. Chang DM, Ding YA, Kuo SY, Chang ML, Wei J: Cytokines and cell surface markers in prediction of cardiac allograft rejection. Immunol Invest 1996;25:13-21.
45. Hutchinson P, Matthew J, Atkins RC, Holdsworth SR: Ex vivo lymphocyte proliferative function is severely inhibited in renal transplant patients on mycophenolate mofetil treatment. Transplant Immunol 2004;13:55-61.
46. Weimer R, Melk A, Daniel V, Friemann S, Padberg W, Opelz G: Switch from cyclosporine A to tacrolimus in renal transplant recipients: impact on Th1, Th2, and monokine responses. Hum Immunol 2000;61:884-897.
47. Hackstein H, Thomson AW: Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol 2004;4:24-35.
48. Mazariegos GV, Zahorchak AF, Reyes J, Chapman H, Zeevi A, Thomson AW: Dendritic cell subset ratio in tolerant, weaning and non-tolerant liver is not affected by extent of immunosuppression. Am J Transplant 2005;5:314-322.
49. Barten MJ, Garbade J, Bittner HB, Fiedler M, Dhein S, Thiery J, Mohr FW, Gummert JF: Affects of immunosuppression on circulating dendritic cells: an adjunct to therapeutic drug monitoring after heart transplantation. Int Immunopharmacol 2006;6:2011-2016.
50. Varani S, Frascaroli G, Gibellini D, Potena L, Lazzarotto T, Lemoli RM, Magelli C, Söderberg-Naucler C, Landini MP: Impaired dendritic cell immunophenotype and function in heart transplant patients undergoing active cytomegalovirus infection. Transplantation 2005;79:219-227.
51. Burger R, Gerlich W, Gürtler L, Heiden M, Hitzler W, Jansen B, Lefevre H, Lower J, Ludwig WD, Montag-Lessing T, Neumann R, Paessens A, Pauli G, Seitz R, Schlenkrich U, Werner E, Willkommen H: Human cytomegalovirus. Transfus Med Hemother 2005;32:160-166.
52. Lutz M, Schuler G: Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 2002;23:445-449.
53. Bocsi J, Mittag A, Sack U, Gerstner AO, Barten MJ, Tárnok A: Novel aspects of systems biology and clinical cytomics. Cytometry A 2006;69A:105-108.
54. Tárnok A: Slide-based cytometry for cytomics - a minireview. Cytometry A 2006;69A:555-562.
55. Mittag A, Lenz D, Gerstner AO, Tárnok A: Hyperchromatic cytometry principles for cytomics using slide based cytometry. Cytometry A 2006;69A:691-703.
56. Laffers W, Schlenkhoff C, Pieper K, Mittag A, Tárnok A, Gerstner AOH: Concepts for absolute immunophenosubtyping by slide-based cytometry. Transfus Med Hemother 2007;34(3):188-195.
57. Brockhoff G, Müller S, Sarraf C, Tárnok A: Predictive medicine and clinical cytomics research: resume of the 15th Annual Meeting of the German Society for Cytometry (Deutsche Desellschaft für Zytometrie, DgfZ). Cell Prolif 2006;39:75-78.
58. Tárnok A, Bocsi J, Brockhoff G: Cytomics - importance of multimodal analysis of cell function and proliferation in oncology. Cell Prolif 2006;39:495-505.
59. Tárnok A, Brockhoff G: Cytomics emerging from cytometry. Cell Prolif 2006;39:335-338.
60. van Gelder T, Hesselink DA, van Hest RM, Mathot RAA, van Schaik R: Pharmacogenetics in immunosuppressive therapy: the best thing since TDM? Ther Drug Monit 2004;26:343-346.